S54 - Ischemic Stroke Prevention

Event Time: Friday April 27, 2018 3:30 pm to 5:30 pm
Topic(s): Cerebrovascular Disease and Interventional Neurology
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
3:30 PM 001 Effect of Extended Thromboprophylaxis with Non-Vitamin K Antagonist Oral Anticoagulant on the Risk of Stroke and Major Bleeding in Acutely Ill Hospitalized Medical Patients: A Meta-Analysis of Randomized Controlled Trials Jolanta Marszalek, MD
Dr. Marszalek has nothing to disclose.

3:42 PM 002 Interarm Systolic and Diastolic Blood Pressure Difference Is Diversely Associated With Cerebral Atherosclerosis in Noncardioembolic Stroke Patients Yoonkyung Chang, MD
Dr. Chang has nothing to disclose.

3:54 PM 003 Systematic Review and Meta-Analysis of Randomized Control Trials Examining Efficacy of CPAP for Prevention of Stroke in Patients with Moderate to Severe Obstructive Sleep Apnea Nida Faheem
Dr. Faheem has nothing to disclose.

4:06 PM 004 Are SNPs associated with large artery disease in Caucasians also significant in intracranial atherosclerotic disease? Thomas Leung, MD
Dr. Leung has nothing to disclose.

4:18 PM 005 Influence of on-going Treatment with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker on the Outcome of Patients treated with Intravenous rt-PA for Ischemic Stroke Sixtine GILLIOT
Dr. GILLIOT has nothing to disclose.

4:30 PM 006 Left Atrial Dilatation: A Cohort Analysis With Strong Implications For Future Atrial Fibrillation And Stroke Monitoring. Muhammad Affan, MD
Dr. Affan has nothing to disclose.

4:42 PM 007 Device closure of patent foramen ovale reduces the risk of stroke compared to medical therapy in patients with cryptogenic ischaemic stroke and PFO: a meta-analysis Yao Feng Victor Chong
Dr. Chong has nothing to disclose.

4:54 PM 008 Therapeutic Regimen of L-arginine for Patients with MELAS: 9-year, Prospective, Multicentre, Clinical Research Integrating the Data from Two 2-year Clinical Trials with 7-year Follow-up Yasutoshi Koga, MD, PhD
Dr. Koga has nothing to disclose.

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses